Gemtuzumab FDA Link

Immunotoxin that consists of an anti-CD33 (CD33 ANTIGEN) monoclonal antibody conjugated to CALICHEAMICIN. It is used for the treatment of ACUTE MYELOID LEUKEMIA.

Also Known As:

Mylotarg; CMA 676; CMA-676; CMA676; Gemtuzumab Ozogamicin; Gemtuzumab-Ozogamicin

Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Calicheamicins: 122
      - Gemtuzumab: 434
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Gemtuzumab: 434
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Gemtuzumab: 434
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Gemtuzumab: 434

Gemtuzumab Products